Abiopharma

ISS and Egan-Jones Join Glass Lewis to Recommend ECAT Shareholders Vote to Support ECAT Board Nominees

LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors

Syntec Optics (Nasdaq: OPTX) Announces Inclusion in Russell 3000 Index

Outlook Therapeutics Announces Resubmission of Biologics License Application to U.S. FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Verisk Redefines U.S. Hurricane Risk Modeling with Reengineered Tropical Cyclone Model, Delivered on Its New Synergy Studio Platform

SABA Announces $0.058 Dividend

BRW Announces $0.085 Dividend

Fusemachines Appoints Renowned AI Pioneer Dr. Julia Hirschberg to Board of Directors

Change in holdings of interested parties/officers - amendment of report

FORM 3-INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES